glp-1 drug news today π medications are finally becoming more accessible in India but this isn't a new conversation for us. There are so many other thjngs and tests to be considered but this Can one drug do it
Description
When paired with GLP-1-mediated insulin secretion, the glycemic destabilization typically associated with pure glucagon agonism is offset, allowing the energy-expenditure benefits to manifest without the counter-regulatory downside
L.ZhongW.ShuJ.Abu MuchA.LotanD.GrupperA.et al (2021)
Blue Cross Blue Shield Blue Care Network of Michigan
Patients in Ro's study lost an average of 16.6% of their body weight over 68 weeks
Early-stage data were striking: weekly injections produced about 22% weight loss over 36 weeks, while the oral form delivered around 13% over 12 weeks, in both cases without a clear plateau
[DOI] [PMC free article] [PubMed] [Google Scholar] 117.Darsalia V., Johansen O.E., Lietzau G., Nystrm T., Klein T., Patrone C
